Calendar

Week of Mar 16, 2026

Mar 16, 2026grant168d agoUNIVERSITY OF WASHINGTON — Serotonin and dopamine dynamics during kappa opioid mediated aversionUniversity of Washington

DA grant. $46,988. PI: Micaela Vela Ruiz

full page →nih reporter ↗

Mar 16, 2026grant168d agoBECKMAN RESEARCH INSTITUTE/CITY OF HOPE — An exosome-based liquid biopsy assay for the non-invasive early detection of ...City of Hope

CA grant. $738,675. PI: Ajay Goel

full page →nih reporter ↗

Mar 16, 2026grant168d agoJOHNS HOPKINS UNIVERSITY — CHARACTERIZING FLAGELLAR MOTILITY IN THE CONTEXT OF HOST-MICROBE SYMBIOSISJohns Hopkins University

GM grant. $388,333. PI: Jonathan Lynch

full page →nih reporter ↗

Mar 16, 2026grant168d agoCALIFORNIA INSTITUTE OF TECHNOLOGY — k-mer based local uniqueness exploration

HG grant. $90,632. PI: Delaney Kalcey Sullivan

full page →nih reporter ↗

Mar 16, 2026grant168d agoICAHN SCHOOL OF MEDICINE AT MOUNT SINAI — Deciphering the genetic, functional, and therapeutic roles of TREM2 in diabet...

DK grant. $656,180. PI: Jia Fu

full page →nih reporter ↗

Mar 16, 2026grant168d agoUNIVERSITY OF TX MD ANDERSON CAN CTR — Mechanistic basis and therapeutic strategies for PPP2R1A mutation in gynecolo...

CA grant. $653,967. PI: Rugang Zhang

full page →nih reporter ↗

Mar 16, 2026grant168d agoUNIVERSITY OF MINNESOTA DULUTH — BRE-SPAD at the University of Minnesota DuluthUniversity of Minnesota

GM grant. $759,572. PI: Erik T Brown

full page →nih reporter ↗

Mar 16, 2026grant168d agoUNIVERSITY OF WASHINGTON — Developmental mechanisms underlying the functional diversification of facial ...University of Washington

HD grant. $46,685. PI: Riku Yasutomi

full page →nih reporter ↗

Mar 16, 2026grant168d agoGORDON RESEARCH CONFERENCES — 2026 Metals in Medicine Gordon Research Conference and Gordon Research Seminar

CA grant. $5,000. PI: Maria Contel

full page →nih reporter ↗

Mar 16, 2026grant168d agoUNIVERSITY OF SOUTH CAROLINA AT COLUMBIA — Recovery from Post-Stroke Aphasia With rTMS Targeting The Anterior Temporal L...

DC grant. $146,004. PI: Sophie Arheix-Parras

full page →nih reporter ↗

Mar 16, 2026grant168d agoUNITED STATES ASSOCIATION FOR THE STUDY OF PAIN, INC. — US Association for the Study of Pain Annual Scientific Meeting

AT grant. $60,000. PI: MICHAEL S GOLD

full page →nih reporter ↗

Mar 17, 2026approval167d agoALYFTREK (DEUTIVACAFTOR) — FDA approval(deutivacaftor + tezacaftor + vanzacaftor calcium)

Sponsor: VERTEX PHARMS INC. Form: TABLET. Route: ORAL

full page →(deutivacaftor + tezacaftor + vanzacaftor calcium) →fda approvals ↗

Mar 17, 2026approval167d agoTRIKAFTA (COPACKAGED) (ELEXACAFTOR, IVACAFTOR, TEZACAFTOR) — FDA approvalTRIKAFTA (COPACKAGED)

Sponsor: VERTEX PHARMS INC. Form: TABLET. Route: ORAL

full page →TRIKAFTA (COPACKAGED) →fda approvals ↗

Mar 17, 2026approval167d agoTRIKAFTA (COPACKAGED) (ELEXACAFTOR, IVACAFTOR, TEZACAFTOR) — FDA approvalTRIKAFTA (COPACKAGED)

Sponsor: VERTEX PHARMS INC. Form: GRANULES. Route: ORAL

full page →TRIKAFTA (COPACKAGED) →fda approvals ↗

Mar 17, 2026approval167d agoORKAMBI (IVACAFTOR) — FDA approval(ivacaftor + lumacaftor)

Sponsor: VERTEX PHARMS INC. Form: GRANULE. Route: ORAL

full page →(ivacaftor + lumacaftor) →fda approvals ↗

Mar 17, 2026approval167d agoICOTYDE (ICOTROKINRA HYDROCHLORIDE) — FDA approvalicotrokinra hydrochloride

Sponsor: JANSSEN BIOTECH. Form: TABLET. Route: ORAL

full page →icotrokinra hydrochloride →fda approvals ↗

Mar 17, 2026approval167d agoKALYDECO (IVACAFTOR) — FDA approvalVertex, Inc.

Sponsor: VERTEX PHARMS. Form: TABLET. Route: ORAL

full page →fda approvals ↗

Mar 17, 2026approval167d agoAK-FLUOR 25% (FLUORESCEIN SODIUM) — FDA approvalLong Grove Pharmaceuticals LLC

Sponsor: LONG GROVE PHARMS. Form: INJECTABLE. Route: INTRAVENOUS

full page →fda approvals ↗

Mar 17, 2026approval167d agoOXALIPLATIN — FDA approvalOXALIPLATIN

Sponsor: ACCORD HLTHCARE. Form: INJECTABLE. Route: INTRAVENOUS

full page →OXALIPLATIN →fda approvals ↗

Mar 17, 2026approval167d agoOXALIPLATIN — FDA approvalOXALIPLATIN

Sponsor: ACCORD HLTHCARE. Form: INJECTABLE. Route: INTRAVENOUS

full page →OXALIPLATIN →fda approvals ↗

Mar 17, 2026approval167d agoKALYDECO (IVACAFTOR) — FDA approvalivacaftor

Sponsor: VERTEX PHARMS INC. Form: GRANULE. Route: ORAL

full page →ivacaftor →fda approvals ↗

Mar 17, 2026approval167d agoPIROXICAM — FDA approvalNostrum Pharmaceuticals LLC

Sponsor: UNICHEM. Form: CAPSULE. Route: ORAL

full page →fda approvals ↗

Mar 17, 2026approval167d agoORKAMBI (IVACAFTOR) — FDA approval(ivacaftor + lumacaftor)

Sponsor: VERTEX PHARMS INC. Form: TABLET. Route: ORAL

full page →(ivacaftor + lumacaftor) →fda approvals ↗

Mar 17, 2026approval167d agoSYMDEKO (COPACKAGED) (IVACAFTOR) — FDA approvalivacaftor

Sponsor: VERTEX PHARMS INC. Form: TABLET. Route: ORAL

full page →ivacaftor →fda approvals ↗

Mar 17, 2026approval167d agoLYNAVOY (LINERIXIBAT) — FDA approvallinerixibat

Sponsor: GLAXOSMITHKLINE. Form: TABLET. Route: ORAL

full page →linerixibat →fda approvals ↗

Mar 17, 2026approval167d agoMICAFUNGIN SODIUM — FDA approvalMICAFUNGIN SODIUM

Sponsor: ASPIRO. Form: INJECTABLE. Route: INTRAVENOUS

full page →MICAFUNGIN SODIUM →fda approvals ↗

Mar 17, 2026approval167d agoTOBRADEX ST (DEXAMETHASONE) — FDA approvalOCULAR THERAPEUTIX, INC

Sponsor: HARROW EYE. Form: SUSPENSION/DROPS. Route: OPHTHALMIC

full page →fda approvals ↗

Mar 17, 2026approval167d agoGAMIFANT (EMAPALUMAB-LZSG) — FDA approvalSobi Inc

Sponsor: NOVIMMUNE S.A.. Form: INJECTABLE. Route: INJECTION

full page →fda approvals ↗

Mar 17, 2026approval167d agoCOMBIGAN (BRIMONIDINE TARTRATE) — FDA approvalLumify

Sponsor: ABBVIE. Form: SOLUTION/DROPS. Route: OPHTHALMIC

full page →Lumify →fda approvals ↗

Mar 17, 2026grant167d agoHANNOVER MEDICAL SCHOOL — The growth factor meteorin-like and its receptor KIT in heart failure

HL grant. $29,270. PI: Lillian Hyde

full page →nih reporter ↗

Mar 17, 2026grant167d agoUNIVERSITY OF CALIFORNIA BERKELEY — Robust and Scalable Machine Learning and Statistical Methods for Genomics

GM grant. $510,183. PI: Yun S Song

full page →nih reporter ↗

Mar 17, 2026grant167d agoUNIVERSITY OF ROCHESTER — A small molecule PROTAC for macular degenerationUniversity of Rochester

NS grant. $744,451. PI: Ruchira Singh

full page →nih reporter ↗

Mar 17, 2026grant167d agoDUKE UNIVERSITY — Epithelial actions of a ubiquitin editor restrict immune-regulated sodium tra...Duke University

DK grant. $821,618. PI: Steven D Crowley

full page →nih reporter ↗

Mar 17, 2026grant167d agoUNIV OF NORTH CAROLINA CHAPEL HILL — Leveraging Inpatient records to characterize the HIV Care continuum in North ...

MH grant. $1,177,156. PI: Thibaut Davy-Mendez

full page →nih reporter ↗

Mar 17, 2026grant167d agoUNIVERSITY OF WASHINGTON — Adaptive Neural control of Respiration in DrosophilaUniversity of Washington

NS grant. $122,769. PI: Yichen Luo

full page →nih reporter ↗

Mar 17, 2026grant167d agoHANNOVER MEDICAL SCHOOL — The growth factor meteorin-like and its receptor KIT in heart failure

HL grant. $4,750. PI: Lillian Hyde

full page →nih reporter ↗

Mar 17, 2026grant167d agoUNIVERSITY OF CONNECTICUT STORRS — Implantable, Degradable Drug Delivery Devices for Non-Opioid Post-Surgical Pa...

EB grant. $39,349. PI: Kelly Anne Burke

full page →nih reporter ↗

Mar 17, 2026grant167d agoBRIGHAM AND WOMEN'S HOSPITAL — SocialBit2: High-fidelity Mobile Sensing of Social Connection after StrokeBrigham and Women's Hospital

NS grant. $716,816. PI: Amar Dhand

full page →nih reporter ↗

Mar 17, 2026grant167d agoYALE UNIVERSITY — Plasma-derived astrocyte-enriched exosomes as a platform for ALS patient stra...

NS grant. $461,197. PI: David Pitt

full page →nih reporter ↗

Mar 17, 2026grant167d agoUNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON — Systemic Lipid Metabolism After Aneurysmal Subarachnoid Hemorrhage (SLIM-SAH)

NS grant. $632,144. PI: Aaron Mark Gusdon

full page →nih reporter ↗

Mar 17, 2026grant167d agoUNIVERSITY OF CONNECTICUT SCH OF MED/DNT — Transposon-mediated genetic manipulation of OPCs to study their role in synap...

NS grant. $471,861. PI: David Christopher Martinelli

full page →nih reporter ↗

Mar 18, 2026approval166d agoVIGABATRIN — FDA approvalPyros Pharmaceuticals Inc.

Sponsor: PH HEALTH. Form: FOR SOLUTION. Route: ORAL

full page →fda approvals ↗

Mar 18, 2026approval166d agoMYCOPHENOLATE MOFETIL — FDA approvalMYCOPHENOLATE MOFETIL

Sponsor: AUROBINDO PHARMA LTD. Form: FOR SUSPENSION. Route: ORAL

full page →MYCOPHENOLATE MOFETIL →fda approvals ↗

Mar 18, 2026approval166d agoVIGABATRIN — FDA approvalVIGABATRIN

Sponsor: AUROBINDO PHARMA LTD. Form: TABLET. Route: ORAL

full page →VIGABATRIN →fda approvals ↗

Mar 18, 2026approval166d agoVIGABATRIN — FDA approvalPyros Pharmaceuticals Inc.

Sponsor: UPSHER SMITH LABS. Form: TABLET. Route: ORAL

full page →fda approvals ↗

Mar 18, 2026approval166d agoSKYRIZI (RISANKIZUMAB-RZAA) — FDA approvalrisankizumab

Sponsor: ABBVIE INC. Form: INJECTABLE. Route: INTRAVENOUS

full page →risankizumab →fda approvals ↗

Mar 18, 2026approval166d agoIOPIDINE (APRACLONIDINE HYDROCHLORIDE) — FDA approvalHARROW, INC.

Sponsor: HARROW EYE. Form: SOLUTION/DROPS. Route: OPHTHALMIC

full page →fda approvals ↗

Mar 18, 2026approval166d agoXTORO (FINAFLOXACIN) — FDA approval

Sponsor: FONSECA BIOSCIENCES. Form: SUSPENSION/DROPS. Route: OTIC

full page →fda approvals ↗

Mar 18, 2026approval166d agoXTORO (FINAFLOXACIN) — FDA approval

Sponsor: FONSECA BIOSCIENCES. Form: SUSPENSION/DROPS. Route: OTIC

full page →fda approvals ↗

Mar 18, 2026approval166d agoVIGABATRIN — FDA approvalAmneal Pharmaceuticals, Inc.

Sponsor: AMNEAL PHARMS. Form: TABLET. Route: ORAL

full page →fda approvals ↗

← prev

page 450 of 475

Week of Mar 16, 2026